Cargando…

Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China

OBJECTIVE: To investigate the in vitro activities of five oxazolidinones in parallel against the reference strains of different mycobacterial species and clinical isolates of Mycobacterium tuberculosis (Mtb), and shed light on the differences in the efficacy of these homolog drugs. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chenqian, Wang, Guirong, Huo, Fengmin, Xue, Yi, Jia, Junnan, Dong, Lingling, Zhao, Liping, Wang, Fen, Huang, Hairong, Duan, Hongfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745032/ https://www.ncbi.nlm.nih.gov/pubmed/36523787 http://dx.doi.org/10.3389/fmed.2022.1067516

Ejemplares similares

Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis
por: Yu, Xia, et al.
Publicado: (2022)

In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2017)

Pulmonary Tuberculosis Caused by Mycobacterium bovis in China
por: Jiang, Guanglu, et al.
Publicado: (2015)

The Practical Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a High Tuberculosis Burden Setting: a Prospective Multicenter Diagnostic Accuracy Study
por: Wang, Guirong, et al.
Publicado: (2022)

Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm
por: Chen, Suting, et al.
Publicado: (2022)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

Extremely high levels of central nervous system involvement in miliary tuberculosis
por: Wang, Guirong, et al.
Publicado: (2022)

EasyNAT MTC assay: A simple, rapid, and low-cost cross-priming amplification method for the detection of mycobacterium tuberculosis suitable for point-of-care testing
por: Zhang, Zhuman, et al.
Publicado: (2021)

Rapid Detection of Ethambutol-Resistant Mycobacterium tuberculosis from Sputum by High-Resolution Melting Analysis in Beijing, China
por: Wang, Jun, et al.
Publicado: (2020)

Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China
por: Huang, Hairong, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
por: Yu, Xia, et al.
Publicado: (2023)

Antibacterial Properties and Computational Insights of Potent Novel Linezolid-Based Oxazolidinones
por: Malik, M. Shaheer, et al.
Publicado: (2023)

Trends and Species Diversity of Non-tuberculous Mycobacteria Isolated From Respiratory Samples in Northern China, 2014–2021
por: Sun, Qing, et al.
Publicado: (2022)

Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Jing, Wei, et al.
Publicado: (2017)

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023)

Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection
por: Lee, Ju Mi, et al.
Publicado: (2023)

Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes
por: Wang, Wei, et al.
Publicado: (2022)

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
por: Yu, Xia, et al.
Publicado: (2021)

A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro
por: Guo, Qi, et al.
Publicado: (2021)

Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus
por: Chen, Suting, et al.
Publicado: (2021)

In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus
por: Zhu, Rui, et al.
Publicado: (2022)

Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex
por: Gao, Tianhui, et al.
Publicado: (2023)

Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China
por: Huo, Fengmin, et al.
Publicado: (2019)

Combination of Percutaneous Lung Biopsy and Xpert MTB/RIF Ultra Enhances the Differential Diagnosis of Tuberculosis: A Prospective Cohort Study
por: Zhou, Zhen, et al.
Publicado: (2020)

Easy Access to Evans’ Oxazolidinones. Stereoselective Synthesis and Antibacterial Activity of a New 2-Oxazolidinone Derivative
por: Diaz, Gaspar, et al.
Publicado: (2014)

Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study
por: Guo, Jidong, et al.
Publicado: (2021)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
por: Zhang, Lei, et al.
Publicado: (2023)

Current Updates on Oxazolidinone and Its Significance
por: Pandit, Neha, et al.
Publicado: (2012)

Oxazolidinones as versatile scaffolds in medicinal chemistry
por: Fernandes, Guilherme Felipe Santos, et al.
Publicado: (2023)

Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China
por: Kong, Yaoyao, et al.
Publicado: (2023)

Evaluation of the efficacy of Myco/F lytic system, MGIT960 system and Lowenstein-Jensen medium for recovery of Mycobacterium tuberculosis from sterile body fluids
por: Wang, Guirong, et al.
Publicado: (2016)

Evaluation of a Simple in-House Test to Presumptively Differentiate Mycobacterium tuberculosis Complex from Nontuberculous Mycobacteria by Detection of p-Nitrobenzoic Acid Metabolites
por: Wang, Guirong, et al.
Publicado: (2013)

CinA mediates multidrug tolerance in Mycobacterium tuberculosis
por: Kreutzfeldt, Kaj M., et al.
Publicado: (2022)

Biological interpretation of the sporadic sputum smear-positive-culture-negative outcome for patients with tuberculosis undertaking treatments
por: Luo, Jingjing, et al.
Publicado: (2023)

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
por: Rattan, A, et al.
Publicado: (1998)

Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia
por: Ferro, Beatriz E., et al.
Publicado: (2011)

MicroRNA signatures from multidrug-resistant Mycobacterium tuberculosis
por: REN, NA, et al.
Publicado: (2015)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin
por: Yu, Xia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rcc6sm3hdbo8r98dv3q8k8q0a1